Camp4 Therapeutics (CAMP) Depreciation & Amortization (CF) (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Depreciation & Amortization (CF) of $520000.0 for Q1 2026, up 23.52% on a YoY basis from $421000.0 in Q1 2025, and up 39.78% sequentially from $372000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $520000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 23.52% year-over-year to $520000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 3.39% YoY), and the FY2025 full-year result was $1.6 million, down 3.36% from the prior year.
- Depreciation & Amortization (CF) improved to $520000.0 in Q1 2026, from $372000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $520000.0 in Q1 2026 to a low of $372000.0 in Q4 2025.
- A 4-year average of $429000.0 and a median of $422500.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) fell 11.0% in 2025 and grew 23.52% in 2026, its largest moves.
- Tracing CAMP's Depreciation & Amortization (CF) over 4 years: stood at $435000.0 in 2023, then fell by 3.91% to $418000.0 in 2024, then retreated by 11.0% to $372000.0 in 2025, then soared by 39.78% to $520000.0 in 2026.
- Business Quant data shows CAMP's Depreciation & Amortization (CF) at $520000.0 in Q1 2026, $372000.0 in Q4 2025, and $416000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | 520,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 520,000.00 |
| Mar 31, 2026 | 520,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Sep 30, 2025 | 416,000.00 |
| Sep 30, 2025 | 416,000.00 |
| Jun 30, 2025 | 430,000.00 |
| Jun 30, 2025 | 430,000.00 |
| Mar 31, 2025 | 421,000.00 |
| Mar 31, 2025 | 421,000.00 |
| Dec 31, 2024 | 418,000.00 |
| Dec 31, 2024 | 418,000.00 |
| Sep 30, 2024 | 418,000.00 |
| Sep 30, 2024 | 418,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 436,000.00 |
| Mar 31, 2024 | 436,000.00 |
| Dec 31, 2023 | 435,000.00 |
| Dec 31, 2023 | 435,000.00 |